Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$0.69 - $1.21 $21 - $37
31 New
31 $0
Q1 2021

May 14, 2021

SELL
$7.19 - $14.95 $72,302 - $150,337
-10,056 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$6.66 - $14.66 $101,105 - $222,553
-15,181 Reduced 60.15%
10,056 $109,000
Q3 2020

Nov 13, 2020

BUY
$8.69 - $14.47 $219,309 - $365,179
25,237 New
25,237 $223,000
Q4 2017

Feb 14, 2018

SELL
$8.45 - $17.48 $88,826 - $183,749
-10,512 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$13.52 - $23.75 $142,122 - $249,660
10,512
10,512 $154,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.05M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.